{"biological_condition":["Treatment: hypoxia(0.2% O2), siCtrl;"],"cell_line":["PC3(bone mets prostate adenocarcinoma)"],"identifier":["30655535","EXP057826","GSE106305","GSM3145502"],"jaspar_id":["MA0259.1","MA1106.1"],"prediction_models":["DAMO"],"tf_id":"EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A","tf_name":"HIF1A","tfbs":[{"DAMO":[{"adj_centrimo_pvalue":-1.84112896613009,"distance_threshold":"69.5","jaspar_id":"MA0259","jaspar_version":"1","score_threshold":"87.1","total_tfbs":"39523","model_detail":"","bed_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A.MA0259.1.damo.bed","fasta_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A.MA0259.1.damo.fa","summary_plot_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A.MA0259.1.damo.png"},{"adj_centrimo_pvalue":-1.73465029742815,"distance_threshold":"59.5","jaspar_id":"MA1106","jaspar_version":"1","score_threshold":"86.6","total_tfbs":"34121","model_detail":"","bed_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A.MA1106.1.damo.bed","fasta_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A.MA1106.1.damo.fa","summary_plot_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A/EXP057826.PC3bone_mets_prostate_adenocarcinoma.HIF1A.MA1106.1.damo.png"}]}],"total_peaks":"61253"}